Nestlé completes Alcon eyecare sale to Novartis

Nestlé completes Alcon eyecare sale to Novartis

Nestlé has concluded the $28bn sale of its majority stake in eyecare business Alcon to Novartis.

 

Already have an account? Sign in here

You’ve used up your article allowance

Sign up to read more stories for free

Register now